D3822

Dipeptidyl Peptidase IV Inhibitor I

≥95% (HPLC), glucagon-like peptide (GLP-1) modulator, solid

• Synonim(y): Diprotin A
• Wzór empiryczny (zapis Hilla): C₁₇H₃₁N₃O₄
• Masa cząsteczkowa: 341.45
• UNSPSC Code: 12352202
• NACRES: NA.77
• Assay: ≥95% (HPLC)

Właściwości

• Nazwa produktu: Dipeptidyl Peptidase IV Inhibitor I,
• assay: ≥95% (HPLC)
• Quality Segment: 200
• form: solid
• color: white
• storage temp.: 2-8°C

Opis

General description

Dipeptidyl peptidase IV (DPP IV) is a member of the prolyl-specific proteases family. It is a dimeric type II integral membrane glycoprotein that is broadly expressed in the epithelial and nonepithelial tissues. It is majorly expressed in the kidney and the colon. 

Application

Dipeptidyl peptidase IV inhibitor I has been used in acute in vivo studies to assess rapid plasma glucagon-like peptide (GLP-1) responses to specified secretory agents in mice.

Biochem/physiol Actions

Dipeptidyl peptidase IV (DPP IV) functions as a modulator of glucagon-like peptide (GLP-1), insulin-stimulating hormones, and glucose-dependent insulinotropic polypeptide (GIP). It is an essential therapeutic target for type 2 diabetes (T2DM). DPP-4 inhibitors are crucial for maintaining glucose homeostasis by prolonging the activity of GLP-1 and GIP. They also enhance glycemic control for a longer period when compared to early oral hypoglycemics. DPP-4 also acts as a binding protein and a ligand of extracellular factors.

Other Notes

Ile-Pro-Ile

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable